PMC:7696151 / 92018-92267
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2747 | 130-133 | Gene | denotes | DCX | Gene:1641 |
| 2762 | 109-112 | Chemical | denotes | HCQ | MESH:D006886 |
| 2763 | 220-223 | Chemical | denotes | DXC | MESH:D004318 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T586 | 0-249 | Sentence | denotes | To date, several case reports available in the literature supported a therapy consisting of a combination of HCQ (600 mg/day) and DCX (200 mg/day) for a lifetime or at least one year, followed by a maintenance dosage of DXC used alone [156,157,158]. |